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mortality from childhood pneumonia 
and seven other main causes of child 
death. If these studies were of a 
questionable quality, the predictive 
power of these models would be poor. 
However, a high R2 (0·58) implies 
a strong (and plausible) relation 
between child mortality and propor-
tional mortality from pneumonia. 
Appendix 4 in our paper shows 
beyond doubt that pneumonia steeply 
declines as a proportional cause of 
death when child mortality declines, 
with narrow conﬁ dence intervals.
The most recent global estimates 
of child mortality for 2008,1 which are 
based on the best available multicause 
evidence from all countries, also show 
a steep rate of decline in pneumonia 
mortality relative to change in 
mortality rate for children younger 
than 5 years during the same period 
and so does the forthcoming global 
single-cause model.
Furthermore, our Chinese col-
leagues cross-validated our cause-
specific estimates against the most 
recent output from the Chinese 
Maternal and Child Surveillance 
system (MCMS), which is nationally 
representative but not in the 
public domain. They found that 
the differences between directly 
observed causes of death within 
MCMS and our modelled estimates 
were within 2% of each other for 
all eight major causes of death in 
2008, which directly confirmed 
the validity of our cause-specific 
predictions for 2008. Therefore, 
we believe that the estimates of 
proportional causes of death in 
our paper should be considered 
reliable and that the rapid decline in 
pneumonia mortality in China can be 
largely explained by a rapid decline in 
the overall mortality rate in children 
younger than 5 years.
The remaining question is whether 
we can trust the Chinese MCMS, 
which was the source of the reported 
declining overall mortality trend. We 
spent time in China with the local 
experts studying the quality of MCMS. 
We can conﬁ rm that the changes in 
MCMS, which we explained in our 
webappendix, have considerably 
improved the quality of this registry. 
Its national representativeness, 
quality-control protocols, and checks 
for under-reporting make it sub-
stantially more reliable than the 
routine reporting system that was in 
place previously.
The reported progress in reduction 
of the mortality rate for children 
younger than 5 years might seem 
spectacular, but there are several 
unique reasons why this should 
perhaps be expected. China has 
addressed child mortality through 
careful central planning and the co-
ordinated, massive improvement in 
social determinants of child survival, 
near-universal primary health care, 
expanded vaccination coverage, 
economic growth, infrastructure de-
velopment, health-systems building, 
integration of minority populations, 
maternal education, improved sani-
tation, and the introduction of the 
“one child” policy. It would not come 
as a surprise if all these parallel positive 
developments have led to un-
precedented levels of reduction in child 
mortality in a multiplicative, rather 
than additive, way.
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International Carotid Stenting Study investigators. 
Carotid artery stenting compared with 
endarterectomy in patients with symptomatic 
carotid stenosis (International Carotid Stenting 
Study): an interim analysis of a randomised 
controlled trial. Lancet 2010; 375: 985–97—In 
this Article (March 20), in the list of 
International Carotid Stenting Study 
investigators (pp 995–96) H-C Nasser’s name 
should have been spelt “H-C Nahser”.
Triglyceride Coronary Disease Genetics 
Consortium and Emerging Risk Factors 
Collaboration. Triglyceride-mediated pathways 
and coronary disease: collaborative analysis of 
101 studies. Lancet 2010; 375: 1634–39—In 
this Article (May 8), J J Kastelein should have 
been listed as a member of the Triglyceride 
Coronary Disease Genetics Consortium 
investigators for Bloodomics.
Vaidya JS, Joseph DJ, Tobias JS, et al. Targeted 
intraoperative radiotherapy versus whole breast 
radiotherapy for breast cancer (TARGIT-A trial): 
an international, prospective, randomised, non-
inferiority phase 3 trial. Lancet 2010; 
376: 91–102—In this Article (published online 
June 5), “Ninewells Cancer Campaign” should 
have been listed in the Funding section of the 
Summary and in the list of funders in the 
Acknowledgments section. Additionally, in 
the list of TARGIT-A team members, 
R Choudhury should have been spelt 
“R Chaudhuri”. These corrections have been 
made to the online version as of July 9, 2010, 
and also to the printed Article.
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